Search Results 181-190 of 16629 for fibrosis quistica

1. A Phase I Study of iPS Cell Generation From Patients With COPD - Mayo Clinic

   ... fibrosis, pulmonary fibrosis and pulmonary hypertension, the investigators will assess the feasibility of collecting skin biopsies from patients undergoing ...

2. Translational Cardiovascular Disease Research Laboratory - Media

   Media. Get a closer look at our research process, learn about our lab's equipment, and explore microscopy images on myocarditis, fibrosis and pericardial ...

3. A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment - Mayo Clinic

   A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment.

4. Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein - Mayo Clinic

   The purpose of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Participation eligibility. Participant eligibility ...

5. Good news about the effectiveness of antifibrotics for IPF

   These drugs are the only medications approved by the Food and Drug Administration for idiopathic pulmonary fibrosis. Although clinical trials had shown that the ...

6. A Study Evaluating Efruxifermin in Subjects with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis - Mayo Clinic

   The purpose of this study is to evaluate efruxifermin (EFX) in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). Participation ...

7. A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension - Mayo Clinic

   A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension ... fibrosis on long term oxygen therapy.

8. Interstitial Lung Disease Clinical Trials - Mayo Clinic Research

   ... Fibrosis Rochester, MN. Systemic Sclerosis (SSc) is a devastating disease of unknown etiology. Patients suffer from multiple organ fibrosis whereas lung ...

9. Teng Moua, M.D. - Mayo Clinic Faculty Profiles

   Moua studies the baseline characteristics and environmental factors of people that lead to the clinical and radiological progression of lung fibrosis.

10. A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis - Mayo Clinic

    A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver ...